S. King

Statistical prediction of drug stability based on nonlinear parameter estimation.

H L Fung, S Y King, M S Kung, 1984, Journal of pharmaceutical sciences.

Dose-Dependent Pharmacokinetics of Warfarin in Healthy Volunteers

H. Pieniaszek, I. Benedek, S. P. King, 1995, Pharmaceutical Research.

Pharmacokinetics of pentaerythritol tetranitrate following intra-arterial and oral dosing in the rat.

H. Fung, S. P. King, S. King, 1986, Journal of pharmaceutical sciences.

Examination of the in vitro degradation of [14C] pentaerythritol tetranitrate in rat and human blood with an improved thin-layer radiochromatographic procedure.

H. Fung, S. King, 1985, Journal of chromatography.

Variability in the Pharmacokinetics and Pharmacodynamics of Low Dose Aspirin in Healthy Male Volunteers

H. Pieniaszek, D. Kornhauser, I. Benedek, 1995, Journal of clinical pharmacology.

Phase I Safety and Pharmacokinetic Studies of Brequinar Sodium after Single Ascending Oral Doses in Stable Renal, Hepatic, and Cardiac Allograft Recipients

A. Menkis, C. Stiller, L. Makowka, 1997, Journal of clinical pharmacology.

Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies

E. Raymond, D. V. Von Hoff, H. Burris, 1998, Investigational New Drugs.

Protein binding of brequinar in the plasma of healthy donors and cancer patients and analysis of the relationship between protein binding and pharmacokinetics in cancer patients

J. Bertino, H. Pieniaszek, Cecilia L Chi, 2004, Cancer Chemotherapy and Pharmacology.